Literature DB >> 9762985

Performing radiologic gastrostomy or gastrojejunostomy in patients with malignant ascites.

J M Ryan1, P F Hahn, P R Mueller.   

Abstract

OBJECTIVE: We describe our protocol for performing decompression radiologic gastrostomy and gastrojejunostomy in patients with ascites and small-bowel obstruction. We also assess the technical success rate, the complications, and the morbidity and mortality in 45 patients who underwent radiologic gastrostomy.
MATERIALS AND METHODS: Forty-five consecutive patients with ascites associated with metastatic ovarian cancer underwent a radiologic gastrostomy or gastrojejunostomy with gastropexy. Six patients underwent gastrostomy, and 39 patients underwent gastrojejunostomy. Locking catheters were placed using the Seldinger technique after gastropexy in all patients. Paracentesis was performed before gastrostomy or gastrojejunostomy. Additional serial paracenteses were performed after the procedure when reaccumulation of ascites close to the site of gastropexy was detected on follow-up sonography.
RESULTS: Forty-five procedures were attempted. The technical success rate was 97.8%. The complication rate was 15.6%. Three major complications (6.7%) and four minor complications (8.9%) occurred. One procedure-related death (2.2%) occurred 16 days after gastrojejunostomy.
CONCLUSION: Radiologic gastrostomy and gastrojejunostomy can be performed safely in patients with ascites if the patients undergo paracentesis first and if the reaccumulation of ascites is prevented after tube placement. In patients with ascites, gastropexy plays an important role in preventing pericatheter leakage. Ascites and peritoneal carcinomatosis should not be considered contraindications for radiologic gastrostomy or gastrojejunostomy.

Entities:  

Mesh:

Year:  1998        PMID: 9762985     DOI: 10.2214/ajr.171.4.9762985

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

Review 1.  Percutaneous Gastrostomy Tube Placement: Recognizing When Things Go Wrong.

Authors:  Peter T Hoang; Christine O Menias; Matthew M Niemeyer
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

Review 2.  Malignant Bowel Obstruction Management Over Time: Are We Doing Anything New? A Current Narrative Review.

Authors:  Farhana Shariff; Jessica Bogach; Keegan Guidolin; Ashlie Nadler
Journal:  Ann Surg Oncol       Date:  2021-10-18       Impact factor: 5.344

3.  Trends and outcomes of percutaneous endoscopic gastrostomy in hospitalized patients with malignant and nonmalignant ascites: a nationwide population study.

Authors:  Ishani Shah; Abhishek Bhurwal; Harsh Mehta; Daniel Maas; Gopala Koneru; Aaron S Cohen; Kambiz S Kadkhodayan
Journal:  Ann Gastroenterol       Date:  2020-09-16

4.  Palliative venting gastrostomy in patients with malignant bowel obstruction and ascites.

Authors:  Colette Shaw; Roland L Bassett; Patricia S Fox; Kathleen M Schmeler; Michael J Overman; Michael J Wallace; Sanjay Gupta; Alda Tam
Journal:  Ann Surg Oncol       Date:  2012-09-11       Impact factor: 5.344

Review 5.  Bowel Obstruction: Decompressive Gastrostomies and Cecostomies.

Authors:  Zoe A Miller; Prasoon Mohan; Robert Tartaglione; Govindarajan Narayanan
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

Review 6.  Decompressive percutaneous gastrostomy tube use in gynecologic malignancies.

Authors:  Larissa Meyer; Bhavana Pothuri
Journal:  Curr Treat Options Oncol       Date:  2006-03

7.  Interventional radiology and the care of the oncology patient.

Authors:  Siobhan B O'Neill; Owen J O'Connor; Max F Ryan; Michael M Maher
Journal:  Radiol Res Pract       Date:  2011-03-29

8.  MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.

Authors:  Ainhoa Madariaga; Jenny Lau; Arunangshu Ghoshal; Tomasz Dzierżanowski; Philip Larkin; Jacek Sobocki; Andrew Dickman; Kate Furness; Rouhi Fazelzad; Gregory B Crawford; Stephanie Lheureux
Journal:  Support Care Cancer       Date:  2022-03-10       Impact factor: 3.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.